{
  "slug": "aoa-dx",
  "name": "Aoa Dx",
  "description": "AOA Dx is a company pioneering lipidomics and an AI-enabled multi-omics platform for life-saving early cancer detection, specifically focusing on women's health, including a novel blood test for early-stage ovarian cancer.",
  "url": "https://optimly.ai/brand/aoa-dx",
  "websiteUrl": "https://aoadx.com/",
  "logoUrl": "https://logo.clearbit.com/aoadx.com",
  "baiScore": 55,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "Cancer Diagnostic Tests",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-09-02T22:29:30.641Z",
  "verifiedVitals": {
    "website": "https://aoadx.com",
    "category": "Biotechnology, Medical Diagnostics, Women's Health",
    "what_it_does": "AOA Dx is a biotechnology company that develops an AI-enabled multi-omics liquid biopsy platform for the early detection of cancer, specifically focusing on women's health. It pioneers lipidomics to identify next-generation biomarkers for early cancer diagnosis, utilizing data science and complementary biomarkers. The company's technology includes a novel blood test, AKRIVIS GD™, which uses AI and multi-omics to detect early-stage ovarian cancer.",
    "primary_audience": "Women (patients) and healthcare providers, particularly within the women's health and oncology diagnostics sectors.",
    "core_product": "The core products are the GlycoLocate™ AI-enabled early detection cancer platform and AKRIVIS GD™, a proprietary liquid biopsy blood test for early-stage ovarian cancer detection.",
    "parent_ownership": null
  },
  "intentTags": {
    "problemIntents": [
      "Difficulty detecting early-stage cancer",
      "Lack of effective early detection platforms for women's health",
      "Need for novel biomarkers in cancer diagnosis",
      "Challenges in diagnosing ovarian cancer early"
    ],
    "solutionIntents": [
      "AI-enabled early cancer detection platform",
      "Multi-omics platform for cancer diagnosis",
      "Lipidomics for biomarker discovery",
      "Blood test for early ovarian cancer detection",
      "Improved diagnostics for women's health"
    ],
    "evaluationIntents": [
      "Evaluate early cancer detection technologies",
      "Compare multi-omics diagnostic platforms",
      "Research novel cancer biomarkers",
      "Assess AI in healthcare diagnostics",
      "Explore women's health diagnostic innovations"
    ]
  },
  "businessProfileClaims": [],
  "timestamp": 1788424609192
}